Will High-Dose Ifosfamide Become the Go-To Therapy in Recurrent Ewing Sarcoma? Data from European rEECur trial "are potentially practice changing," expert says Jun 05, 2022
Third-Line BTK Inhibitor Combo Doubles PFS in Follicular Lymphoma Significantly more responses, CRs with zanubrutinib-obinutuzumab versus anti-CD20 drug alone Jun 05, 2022
Capivasertib-Fulvestrant Combo Ups Survival in ER+/HER2- Metastatic Breast Cancer But benefit seems to be predominantly in patients with PI3K/AKT/PTEN pathway alterations Jun 05, 2022
Sacituzumab Govitecan Boosts PFS in Late-Line HR+/HER2- Metastatic Breast Cancer "This may be something that really changes the lives of these women for the better," expert says Jun 05, 2022
Immunotherapy Rechallenge in NSCLC Yields Overall Survival Boost Phase II trial sees "synergistic benefit" with checkpoint blockade and anti-angiogenesis Jun 04, 2022
IL-15 Agonist Impresses in Non-Muscle Invasive Bladder Cancer High response rate, 99%-100% cancer-specific survival at 2 years Jun 04, 2022
Brentuximab Vedotin-Chemo Boosts EFS in High-Risk Pediatric Hodgkin Lymphoma Combo regimen offers "a new standard for front-line therapy," researcher says Jun 04, 2022
KRAS Inhibitor Shrinks Tumors in Over 40% of NSCLC Patients Median survival surpasses 1 year in heavily pretreated population Jun 03, 2022
Bariatric Surgery Cuts Cancer Incidence, Death Risk Study looked at people with obesity who underwent two most popular procedures Jun 03, 2022
5-Year Interval for Cervical Cancer Screening Safe in HPV-Negative Women U.K. study also supports accuracy of HPV testing versus cytology Jun 03, 2022
Colonoscopy With a Computer-Aided Device Boosted Adenoma Detection Use of the device led to a 27% increase in adenomas per colonoscopy versus standard procedure Jun 03, 2022
Add-On Ibrutinib Boosts PFS in Untreated, Older Mantle-Cell Lymphoma Patients BTK inhibitor plus chemoimmunotherapy increased progression-free survival by over 2 years Jun 03, 2022
Survival Bump With EGFR Inhibitor for KRAS Wild-Type Pancreatic Cancer But generalizability of "notable" Chinese study questioned Jun 03, 2022
AI Shows Promise in Predicting Optimal Margin Width for CRC Liver Mets A 7-mm margin width linked with prolonged survival Jun 02, 2022
Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer More than half of everolimus-treated patients permanently discontinued treatment Jun 02, 2022
T-Cell Receptor Gene Therapy Shows Promise in Pancreatic Cancer Novel treatment targeting KRAS G12D expression induces deep and durable response Jun 01, 2022
FDA Pulls Lymphoma Approvals for PI3K Inhibitor Umbralisib Worse overall survival observed despite improvements in progression-free survival Jun 01, 2022
Doc Gets Prison for COVID 'Cure'; Proton Therapy Gold Rush; Blackfeet Opioid Crisis This past week in healthcare investigations Jun 01, 2022
Increased Public Assistance Tied to Better Cancer Survival in Black Patients Disparity in 5-year OS declined by more than 40% with each 10% boost in public welfare spending May 31, 2022
Is U.S. 'Getting Its Money's Worth' When It Comes to Cancer Care? Cost/mortality benefit pales in comparison with other high-income countries, according to study May 31, 2022
Prone Beats Supine Positioning for WBRT in Women With Large Breasts Prone position led to lower rates of moist desquamation May 27, 2022
Cancer Outcome Disparities Not Fully Explained by Race, Socioeconomic Factors Worse 5-year OS in Hispanic children with high-risk neuroblastoma in adjusted analysis May 27, 2022
Unprecedented PFS Improvement in Relapsed Multiple Myeloma Three-year median with addition of isatuximab to proteasome inhibitor backbone May 26, 2022
Black Patients Often Never Given a Chance to Join Breast Cancer Trials But survey finds several actionable findings that could boost enrollment May 26, 2022
COVID Increased Use of Telemedicine for Cancer Care, Though Not Equitably Black, uninsured, non-urban patients less likely to use these services May 26, 2022
Just How Effective Is PSA Screening? Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
Younger People More Likely to Undergo Colonoscopy After Guideline Change But most colonoscopies still done in those ages 50-54 May 17, 2022
Mental Health Issues Common, Often Overlooked in Prostate Cancer More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
Urologists Are Helping Combat the Opioid Epidemic, Studies Suggest Three reports show success in reducing opioid prescribing May 16, 2022
Robotic Surgery Wins for Keeping Bladder Cancer Patients Alive, Out of Hospital Approach bested open surgery in iROC trial, but is the difference clinically important? May 15, 2022
Combo Treatment Scores Big in BCG-Unresponsive Bladder Cancer Significantly durable response with VesAnktiva-Bacillus Calmette-GuΓ©rin duo May 15, 2022
Concerning Spike in Barrett's Esophagus, Esophageal Cancer in Middle-Age Adults Should these patients undergo screening, especially if they have risk factors? May 15, 2022
Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancer Prescribing rate is half that of women with no breast cancer history May 13, 2022
Could Gallstone Disease Predict Pancreatic Cancer? Researchers urge more attention to gallstone disease patients with atypical symptoms May 13, 2022
Elotuzumab Combination Disappoints in Newly Diagnosed Myeloma Study failed to replicate positive results seen in relapsed/refractory setting May 11, 2022
Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapy Preliminary data on acitretin therapy are promising May 11, 2022
Self-Collected Menstrual Blood to Detect HPV? "Not just a waste product," researcher says May 09, 2022
Novel Combo Falters in Metastatic Triple-Negative Breast Cancer No PFS benefit with addition of ceralasertib to olaparib May 05, 2022
Screening, Early Detection Remain Keys to Lower Cancer Mortality Presidential panel sets course to remove barriers, increase services, and improve uptake May 05, 2022
Antibody-Drug Conjugate Promising for Breast Cancer With Brain Mets High intracranial response rates with trastuzumab-deruxtecan observed in TUXEDO-1 trial May 04, 2022
